Niacin/simvastatin
From Infogalactic: the planetary knowledge core
| File:Niacinstr.png | |
 |
|
| Combination of | |
|---|---|
| Niacin | Vitamin |
| Simvastatin | Statin |
| Clinical data | |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration |
Oral |
| (verify) | |
Niacin/simvastatin (trade name Simcor, by Abbott) is a combination drug consisting of an extended release form of the vitamin niacin and the statin drug simvastatin. It is used for the treatment of dyslipidemia. It was approved by the FDA on February 15, 2008.[1]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
Categories:
- Pages with reference errors
- Pages with broken file links
- Drugs that are a combination of chemicals
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Hypolipidemic agents
- Combination drugs
- Cardiovascular system drug stubs
